Comparison of Idecabtagene Vicleucel With Real-World Outcomes in Relapsed and Refractory Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood Cancer Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
KarMMa-RW: Comparison of Idecabtagene Vicleucel With Real-World Outcomes in Relapsed and Refractory Multiple Myeloma
Blood Cancer J 2021 Jun 18;11(6)116, S Jagannath, Y Lin, H Goldschmidt, D Reece, A Nooka, A Senin, P Rodriguez-Otero, R Powles, K Matsue, N Shah, LD Anderson, M Streetly, K Wilson, HV Le, AS Swern, A Agarwal, DS SiegelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.